Ionis Pharmaceuticals CEO sells $1.23 million in stock
Brett P. Monia, the Chief Executive Officer of Ionis Pharmaceuticals Inc. (NASDAQ:IONS), sold 38,843 shares of the company's common stock on February 4, according to a recent SEC filing. The sale ...
Ionis Pharmaceuticals EVP sells $194,939 in stock
Patrick R. O'Neil, Executive Vice President, Chief Legal Officer & General Counsel of Ionis Pharmaceuticals Inc. (NASDAQ:IONS), recently sold 6,165 shares of the company's common stock. The shares ...
SMA4d
COVID-19 made life more difficult with SMA, parents and doctors say
In surveys, parents of children with SMA and healthcare professionals in Sweden note the many ways the pandemic affected ...
Managed Healthcare Executive6d
FDA Approves Journavx, New Nonopioid Med, for Acute Pain
The FDA recently approved Vertex Pharmaceuticals Incorporated’s Journavx (suzetrigine), a first-in-class non-opioid ...